AvalonBay Communities
Risk Level:
Summary:
AvalonBay Communities has not terminated business relationships due to ideological beliefs, though it does vet suppliers according to LGBTQ policies. AvalonBay Communities does not have viewpoint protections for its employees. The company has supported the Equality Act and finances groups that provide "hormone therapy" for transgender individuals. For these reasons, AvalonBay receives a "Medium Risk" rating.
Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
AvalonBay Communities received a score of 100 on the Corporate Equality Index from the Human Rights Campaign. Among other requirements, this means the company has pledged to vet vendors based on LGBTQ policies (1).
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
AvalonBay Communities does not discriminate against faith-based charities in its giving and partners with faith-based groups such as the Salvation Army and Habitat for Humanity (1).
Employment policies fail to protect against discrimination based on political affiliation/views and/or religion.
AvalonBay Communities does not protect its employees against viewpoint discrimination (1).
Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
AvalonBay Communities donates to Los Angeles LGBT Center JVS SoCal, an organization that provides “transgender” people with “Hormone therapy, including education and management” and “Pre- and post-surgical care” (1).
Uses corporate political contributions for ideological, non-business purposes.
AvalonBay Communities does not have an active PAC.
All links were last accessed and all information was updated on:
March 24, 2023
Company reports are intended for educational use only. Full Disclaimer